{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T19:10:48Z","timestamp":1760987448346},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>There is a poor correlation between total concentrations of proton-accepting compounds (most basic drugs) in unstimulated oral fluid and in plasma. The aim of this study was to compare clozapine, norclozapine, and amisulpride concentrations in plasma and in oral fluid collected using commercially available collection devices [Thermo Fisher Scientific Oral-Eze and Greiner Bio-One (GBO)].<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Oral-Eze and GBO samples and plasma were collected in that order from patients prescribed clozapine. Analyte concentrations were measured by liquid chromatography\u2013tandem mass spectrometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>There were 112 participants [96 men, aged (median, range) 47 (21\u201365) years and 16 women, aged 44 (21\u201365) years]: 74 participants provided 2 sets of samples and 7 provided 3 sets (overall 2 GBO samples not collected). Twenty-three patients were co-prescribed amisulpride, of whom 17 provided 2 sets of samples and 1 provided 3 sets. The median (range) oral fluid within the GBO samples was 52 (13%\u201386%). Nonadherence to clozapine was identified in all 3 samples in one instance. After correction for oral fluid content, analyte concentrations in the GBO and Oral-Eze samples were poorly correlated with plasma clozapine and norclozapine (R<jats:sup>2<\/jats:sup>= 0.57\u20130.63) and plasma amisulpride (R<jats:sup>2<\/jats:sup>= 0.65\u20130.72). Analyte concentrations in the 2 sets of oral fluid samples were likewise poorly correlated (R<jats:sup>2<\/jats:sup>= 0.68\u20130.84). Mean (SD) plasma clozapine and norclozapine were 0.60 (0.46) and 0.25 (0.21) mg\/L, respectively. Mean clozapine and norclozapine concentrations in the 2 sets of oral fluid samples were similar to those in plasma (0.9\u20131.8 times higher), that is, approximately 2- to 3-fold higher than those in unstimulated oral fluid. The mean (\u00b1SD) amisulpride concentrations (microgram per liter) in plasma (446 \u00b1 297) and in the Oral-Eze samples (501 \u00b1 461) were comparable and much higher than those in the GBO samples (233 \u00b1 318).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Oral fluid collected using either the GBO system or the Oral-Eze system cannot be used for quantitative clozapine and\/or amisulpride therapeutic drug monitoring.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ftd.0000000000000377","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T23:27:12Z","timestamp":1485386832000},"page":"109-117","source":"Crossref","is-referenced-by-count":9,"title":["Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems"],"prefix":"10.1097","volume":"39","author":[{"given":"Danielle S.","family":"Fisher","sequence":"first","affiliation":[{"name":"Viapath Analytics, Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital;"},{"name":"Institute of Pharmaceutical Science Research Division, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Beyer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine and Health Sciences, University of Stellenbosch, Tygerberg, Republic of South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"van Schalkwyk","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine and Health Sciences, University of Stellenbosch, Tygerberg, Republic of South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Seedat","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine and Health Sciences, University of Stellenbosch, Tygerberg, Republic of South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Viapath Analytics, Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King's College Hospital;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/FTD.0b013e318283eaf2","article-title":"Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples","volume":"35","author":"Fisher","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cca.2014.12.008","article-title":"Advances in detection of antipsychotics in biological matrices","volume":"441","author":"Patteet","year":"2015","journal-title":"Clin Chim Acta."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FTD.0000000000000242","article-title":"Determination of common antipsychotics in Quantisal-collected oral fluid by UHPLC-MS\/MS: method validation and applicability for therapeutic drug monitoring","volume":"38","author":"Patteet","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1196\/annals.1384.001","article-title":"The use of oral fluid for therapeutic drug management: clinical and forensic toxicology","volume":"1098","author":"Langman","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12011-011-9295-3","article-title":"Relationship between serum lithium, salivary lithium, and urinary lithium in patients on lithium therapy","volume":"147","author":"Shetty","year":"2012","journal-title":"Biol Trace Elem Res."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/clinchem\/23.2.157","article-title":"Use of saliva in therapeutic drug monitoring","volume":"23","author":"Horning","year":"1977","journal-title":"Clin Chem."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jat\/17.6.338","article-title":"Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions","volume":"17","author":"Kato","year":"1993","journal-title":"J Anal Toxicol."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/32.6.393","article-title":"Drug testing in oral fluid-evaluation of sample collection devices","volume":"32","author":"Langel","year":"2008","journal-title":"J Anal Toxicol."},{"key":"R10-20230814","first-page":"556","article-title":"Comparing serum to saliva acetaminophen kinetics","volume":"33","author":"Nemecek","year":"2011","journal-title":"Ther Drug Monit."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.forsciint.2013.02.010","article-title":"LC-MS\/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood","volume":"229","author":"Fisher","year":"2013","journal-title":"Forensic Sci Int."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2125.1998.00822.x","article-title":"Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance","volume":"46","author":"Schaber","year":"1998","journal-title":"Br J Clin Pharmacol."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.euroneuro.2003.09.001","article-title":"Plasma amisulpride levels in schizophrenia or schizoaffective disorder","volume":"14","author":"Bergemann","year":"2004","journal-title":"Eur Neuropsychopharmacol."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.forsciint.2004.10.026","article-title":"Review: the physiology of saliva and transfer of drugs into saliva","volume":"150","author":"Aps","year":"2005","journal-title":"Forensic Sci Int."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/15622975.2010.527370","article-title":"Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation","volume":"12","author":"Kreinin","year":"2011","journal-title":"World J Biol Psychiatr."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1902\/jop.2015.150254","article-title":"Comparative analysis of calcium-binding myeloid-related protein-8\/14 in saliva and serum of patients with periodontitis and healthy individuals","volume":"87","author":"Haririan","year":"2016","journal-title":"J Periodontol."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/jat\/bkv123","article-title":"Influence of sampling procedure on codeine concentrations in oral fluid","volume":"40","author":"Coucke","year":"2016","journal-title":"J Anal Toxicol."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181ae46ea","article-title":"Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs","volume":"31","author":"Wille","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/dta.1532","article-title":"Comparison of drug concentrations between whole blood and oral fluid","volume":"6","author":"Langel","year":"2014","journal-title":"Drug Test Anal."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","article-title":"Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993\u20132007","volume":"32","author":"Couchman","year":"2010","journal-title":"Ther Drug Monit."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jash.2016.03.194","article-title":"A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension","volume":"10","author":"Corr\u00eaa","year":"2016","journal-title":"J Am Soc Hypertens."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"615","DOI":"10.11124\/jbisrir-2012-64","article-title":"Strategies to promote adherence to treatment by pulmonary tuberculosis patients: a systematic review","volume":"10","author":"Suwannakeeree","year":"2012","journal-title":"JBI Libr Syst Rev."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201704000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T02:19:11Z","timestamp":1719022751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201704000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000377","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}